These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Prevention and reversal of obesity and glucose intolerance in mice by DHA derivatives. Rossmeisl M; Jelenik T; Jilkova Z; Slamova K; Kus V; Hensler M; Medrikova D; Povysil C; Flachs P; Mohamed-Ali V; Bryhn M; Berge K; Holmeide AK; Kopecky J Obesity (Silver Spring); 2009 May; 17(5):1023-31. PubMed ID: 19148125 [TBL] [Abstract][Full Text] [Related]
7. Dietary polyunsaturated fatty acids (C18:2 omega6 and C18:3 omega3) do not suppress hepatic lipogenesis. Sealls W; Gonzalez M; Brosnan MJ; Black PN; DiRusso CC Biochim Biophys Acta; 2008 Aug; 1781(8):406-14. PubMed ID: 18655845 [TBL] [Abstract][Full Text] [Related]
8. n-3 polyunsaturated fatty acids in phospholipid or triacylglycerol form attenuate nonalcoholic fatty liver disease via mediating cannabinoid receptor 1/adiponectin/ceramide pathway. Chen YF; Fan ZK; Gao X; Zhou F; Guo XF; Sinclair AJ; Li D J Nutr Biochem; 2024 Jan; 123():109484. PubMed ID: 37866428 [TBL] [Abstract][Full Text] [Related]
9. Eicosapentaenoic and docosahexaenoic acid-enriched high fat diet delays the development of fatty liver in mice. Soni NK; Nookaew I; Sandberg AS; Gabrielsson BG Lipids Health Dis; 2015 Jul; 14():74. PubMed ID: 26193881 [TBL] [Abstract][Full Text] [Related]
10. Prevention of liver steatosis through fish oil supplementation: correlation of oxidative stress with insulin resistance and liver fatty acid content. Espinosa A; Valenzuela R; González-Mañán D; D'Espessailles A; Guillermo Gormaz J; Barrera C; Tapia G Arch Latinoam Nutr; 2013 Mar; 63(1):29-36. PubMed ID: 24167955 [TBL] [Abstract][Full Text] [Related]
11. Differential effects of EPA, DPA and DHA on cardio-metabolic risk factors in high-fat diet fed mice. Guo XF; Sinclair AJ; Kaur G; Li D Prostaglandins Leukot Essent Fatty Acids; 2018 Sep; 136():47-55. PubMed ID: 29113747 [TBL] [Abstract][Full Text] [Related]
12. Dietary Starfish Oil Prevents Hepatic Steatosis and Hyperlipidemia in C57BL/6N Mice Fed High-fat Diet. Beppu F; Li H; Yoshinaga K; Nagai T; Yoshinda A; Kubo A; Kanda J; Gotoh N J Oleo Sci; 2017 Jul; 66(7):761-769. PubMed ID: 28626141 [TBL] [Abstract][Full Text] [Related]
18. Activation of peroxisome proliferator-activated receptor alpha by dietary fish oil attenuates steatosis, but does not prevent experimental steatohepatitis because of hepatic lipoperoxide accumulation. Larter CZ; Yeh MM; Cheng J; Williams J; Brown S; dela Pena A; Bell-Anderson KS; Farrell GC J Gastroenterol Hepatol; 2008 Feb; 23(2):267-75. PubMed ID: 17868330 [TBL] [Abstract][Full Text] [Related]
19. Daidzein supplementation prevents non-alcoholic fatty liver disease through alternation of hepatic gene expression profiles and adipocyte metabolism. Kim MH; Park JS; Jung JW; Byun KW; Kang KS; Lee YS Int J Obes (Lond); 2011 Aug; 35(8):1019-30. PubMed ID: 21157426 [TBL] [Abstract][Full Text] [Related]
20. Differential effects of n-3 polyunsaturated fatty acids on metabolic control and vascular reactivity in the type 2 diabetic ob/ob mouse. Mustad VA; Demichele S; Huang YS; Mika A; Lubbers N; Berthiaume N; Polakowski J; Zinker B Metabolism; 2006 Oct; 55(10):1365-74. PubMed ID: 16979408 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]